Intellia Therapeutics Inc (NASDAQ:NTLA)
| 16.50 Delayed Data As of 4:00pm ET |  -0.31 / -1.84%Today’s Change | 10.26 Today|||52-Week Range 19.00 | +20.88% Year-to-Date |
Latest NTLA News | Press Releases
No recent news for Intellia Therapeutics Inc.
Today’s Trading
| Previous close | 16.81 |
| Today’s open | 16.82 |
| Day’s range | 16.23 - 17.04 |
| Volume | 526,487 |
| Average volume (3 months) | 552,507 |
| Market cap | $835.4M |
Data as of 4:00pm ET, 12/13/2019
Growth & Valuation
| Earnings growth (last year) | -5.40% |
| Earnings growth (this year) | -5.86% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +16.53% |
| P/E ratio | NM |
| Price/Sales | 19.32 |
| Price/Book | 2.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| XBITXBiotech Inc | +0.09 | +0.46% |
| TWSTTwist Bioscience Cor... | +0.30 | +1.15% |
| STOKStoke Therapeutics I... | +0.34 | +1.43% |
| ATRAAtara Biotherapeutic... | -0.54 | -3.38% |
Data as of 4:00pm ET, 12/13/2019
Financials
| Next reporting date | March 11, 2020 |
| EPS forecast (this quarter) | -$0.55 |
| Annual revenue (last year) | $30.4M |
| Annual profit (last year) | -$85.3M |
| Net profit margin | -280.42% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
